These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 192436)

  • 1. Immunodiagnostic potential of a virus-coded, tumor-associated antigen (AG-4) in cervical cancer.
    Aurelian L; Strnad BC; Smith MF
    Cancer; 1977 Apr; 39(4 Suppl):1834-49. PubMed ID: 192436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpesvirus type 2-related antigens and their relevance to humoral and cell-mediated immunity in patients with cervical cancer.
    Aurelian L; Strnad BC
    Cancer Res; 1976 Feb; 36(2 pt 2):810-20. PubMed ID: 175945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viruses and gynecologic cancers: herpesvirus protein (ICP 10/AG-4), a cervical tumor antigen that fulfills the criteria for a marker of carcinogenicity.
    Aurelian L; Kessler II; Rosenshein NB; Barbour G
    Cancer; 1981 Jul; 48(2 Suppl):455-71. PubMed ID: 7023662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgM antibody to a tumor-associated antigen (AG-4) induced by herpes simplex virus type 2: its use in location of the antigen in infected cells.
    Aurelian L; Smith MF; Cornish DJ
    J Natl Cancer Inst; 1976 Mar; 56(3):471-7. PubMed ID: 176392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of herpes simplex virus tumor-associated antigen in uterine cervical cancer tissue: five case studies.
    Notter MF; Docherty JJ; Mortel R; Hollinshead AC
    Gynecol Oncol; 1978 Dec; 6(6):574-81. PubMed ID: 220150
    [No Abstract]   [Full Text] [Related]  

  • 6. An evaluation of herpes simplex virus antigenic markers in the study of established and developing cervical neoplasia.
    Smith CC; Aurelian L; Gupta PK; Frost JK; Rosenshein NB; Klacsmann K; Geddes S
    Anal Quant Cytol; 1980 Jun; 2(2):131-43. PubMed ID: 6255843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative diagnostic aspects of herpes simplex virus tumor-associated antigens.
    Notter MF; Docherty JJ
    J Natl Cancer Inst; 1976 Sep; 57(3):483-8. PubMed ID: 185398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies demonstrating the immunological identity of the tumour-associated antigen AG-4 with a virion envelope protein.
    Strnad BC; Smith MF; Aurelian L
    IARC Sci Publ (1971); 1978; (24 Pt 1):203-13. PubMed ID: 87365
    [No Abstract]   [Full Text] [Related]  

  • 9. Herpes simplex virus. An expanding relationship to human cancer.
    Smith JW
    J Reprod Med; 1983 Feb; 28(2):116-22. PubMed ID: 6300393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reaction of antigens isolated from herpes simplex virus-transformed cells with sera of squamous cell carcinoma patients.
    Notter MF; Docherty JJ
    Cancer Res; 1976 Dec; 36(12):4394-401. PubMed ID: 187320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic and biochemical characterization of individual polypeptides induced by herpes simplex virus types 1 and 2.
    Courtney RJ
    Adv Pathobiol; 1976; (5):87-103. PubMed ID: 220860
    [No Abstract]   [Full Text] [Related]  

  • 12. Elution of herpes simplex virus-specific cytotoxic antibodies from squamous cell carcinoma of uterine cervix.
    Seth P; Balachandran N
    Nature; 1980 Aug; 286(5773):613-5. PubMed ID: 6250079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus-host cell interactions.
    Kucera LS
    CRC Crit Rev Microbiol; 1979 Nov; 7(3):215-44. PubMed ID: 232032
    [No Abstract]   [Full Text] [Related]  

  • 14. [Relationship between Herpes simplex virus type 2 and carcinoma of the uterine cervix].
    Janda J
    Cesk Gynekol; 1973 Jul; 38(6):454-60. PubMed ID: 4354419
    [No Abstract]   [Full Text] [Related]  

  • 15. [Correlation of human papilloma virus (HPV) and herpes simplex virus-2 (HSV-2)in the viral etiology of carcinoma of uterine cervix].
    Meng XJ
    Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):108-10. PubMed ID: 2553361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of herpes simplex virus in cervical and vulvar cancer.
    Melnick JL; Dreesman GR; Adam E; Kaufman R
    Dev Biol Stand; 1982; 52():87-94. PubMed ID: 6299862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes virus-related antigens in herpes simplex virus type 2-transformed cells in the course of cervical carcinoma.
    Christenson B
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1345-52. PubMed ID: 6299751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New antigens induced by herpes simplex virus in human tumors].
    Posevaia TA; Grigor'ev VV; Kosiakova NP; Barinskiĭ IF
    Vopr Virusol; 1981; (2):193-5. PubMed ID: 6267821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein analysis of herpes simplex virus latency in vitro established with cycloheximide.
    Shiraki K; Rapp F
    Virology; 1989 Sep; 172(1):346-9. PubMed ID: 2549718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genital herpes virus findings in relation to cervical neoplasia.
    Royston I; Aurelian L; Davis HJ
    J Reprod Med; 1970 Apr; 4(4):9-13. PubMed ID: 4328889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.